Search Results - "Manikhas, G.M"

Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer by Green, M. R., Manikhas, G. M., Orlov, S., Afanasyev, B., Makhson, A. M., Bhar, P., Hawkins, M. J.

“…Background: Abraxane® (ABI-007) is a novel 130-nm, albumin-bound (nab™) particle form of paclitaxel designed to utilize endogenous albumin pathways to increase…”
Get full text

PO-122: The Prognostic Role of Epidemiological Factors in Prognosis of Recurrent HNSCC by Kutukova, S, Yaremenko, A.I, Ermakova, T.S, Manikhas, G.M

Get full text

PO-099: The Prognostic Importance of Molecular-Genetics and Morphological Factors in Prognosis of Recurrent HNSCC by Kutukova, S.I, Yaremenko, A.I, Manikhas, G.M, Dibirov, R.K

Get full text

PO-059: The Role of Tumour Markers and Clinico-Laboratories Result in Prognosis of Relapse Oral Squamous Cell Carcinoma by Kutukova, S.I, Yaremenko, A.I, Manikhas, G.M, Bozhor, S.S

Get full text

5060 POSTER Albumin-bound Paclitaxel (ab-pac) Versus Docetaxel for First-line Treatment of Metastatic Breast Cancer (MBC): Overall Survival (OS) Subset Analyses of a Randomized Phase 2 Trial by Gradishar, W.J, Krasnojon, D.A, Cheporov, S.V, Makhson, A.N, Manikhas, G.M, Clawson, A, Bhar, P

Get full text

3541 POSTER HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer by Lordick, F, Bang, Y.J, Kang, Y.K, Otero Reyes, D, Manikhas, G.M, Shen, L, Kulikov, E, Stoss, O, Jordan, B.W.M, van Cutsem, E

Get full text

2030 ORAL Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the NOAH ( N e OA djuvant Herceptin) Phase III trial by Baselga, J, Semiglazov, V, Manikhas, G.M, Eiermann, W, Lluch, A, Tjulandin, S, Feyereislova, A, Vanhauwere, B, Valagussa, P, Gianni, L

Get full text

2108 POSTER Cardiac safety of trastuzumab in combination with epirubicin/ cyclophosphamide as first-line therapy in patients with HER2-positive metastatic breast cancer by Untch, M, Tjulandin, S, Jonat, W, Meerpohl, H, Lichinitser, M, Manikhas, G.M, Jänicke, F, Muscholl, M, Pauschinger, M, Lehle, M

Get full text

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy by Aapro, MS, Grunberg, SM, Manikhas, GM, Olivares, G, Suarez, T, Tjulandin, SA, Bertoli, LF, Yunus, F, Morrica, B, Lordick, F, Macciocchi, A

“…Background: This pivotal phase III trial evaluated the efficacy and safety of palonosetron in preventing acute and delayed chemotherapy-induced nausea and…”
Get full text

Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0 by Manikhas, A.G., Grinev, I.A., Oganesian, A.S., Chikrizov, S.I., Manikhas, G.M.

“…Relevance. Breast cancer is the leading oncological disease among female population. In some cases, clinical stage T2N0M0 is contraindication to…”
Get full text

15 - The benefit of endoscopic metastasectomy compared to open surgery in advanced renal cell carcinoma (mRCC). Results of a multicentre retrospective trial by Borisov, P., Orlova, R.V., Shkolnik, M.I., Manikhas, G.M., Karlov, P.A.

Get full text

The benefit of endoscopic metastasectomy compared to open surgery in advanced renal cell carcinoma (mRCC). Results of a multicentre retrospective trial by Borisov, P., Orlova, R.V., Shkolnik, M.I., Manikhas, G.M., Karlov, P.A.

Get full text